CVS agreed to buy medical provider Coram from Apria Healthcare for roughly $2.1 billion, continuing its push into the specialty drug market.
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304747004579223793663456878.html?mod=pls_whats_news_us_business_f
via IFTTT
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304747004579223793663456878.html?mod=pls_whats_news_us_business_f
via IFTTT
No comments:
Post a Comment